European Accelerated Regulatory Pathways Show Momentum

The European Medicines Agency (EMA) has launched a new expedited approval pathway similar to those available in the US to facilitate access to medicines for patients in the European Union (EU). European regulators introduced the PRIority MEdicines (PRIME) approval pathway … Read More